Importance Cervical cancer can be prevented with detection and treatment of precancerous
cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the …

Importance The number of deaths from cervical cancer in the United States has decreased
substantially since the implementation of widespread cervical cancer screening and has …

ABSTRACT A group of 47 experts representing 23 professional societies, national and
international health organizations, and federal agencies met in Bethesda, MD, September …

Objective The aim of the study was to examine whether high-grade cervical intraepithelial
neoplasia (CIN) was more closely associated with human papillomavirus (HPV) same …

Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is
under consideration in the United States as an alternative to the two recommended cervical …

BACKGROUND In the United States, human papillomavirus (HPV) and Papanicolaou (Pap)
testing (cotesting) for cervical screening in women ages 30 to 65 years is the preferred …

Objectives Given the recent debate challenging the contribution of cytology in cervical
screening, we evaluated results of liquid-based cytology (LBC) and human papillomavirus …

The policy recommends cytology-based screening every three years from 25 to 30 years of
age, followed by HPV-based screening every five years from 30 to 65 years of age (Exhibit …

Background Cervical cytology remains widely used as the initial tool in cervical cancer
screening worldwide. WHO guidelines recommend replacing cytology with primary HPV …

The effective management of women with human papillomavirus (HPV)-positive, cytology-
negative results is critical to the introduction of HPV testing into cervical screening. HPV …